| Prev Close | 157.26 |
| Open | 157.59 |
| Day Low/High | 148.51 / 157.82 |
| 52 Wk Low/High | 17.68 / 178.50 |
| Volume | 27.59M |
Moderna, Inc. (MRNA)
152.88
4.40
2.80
NASDAQ
| Exchange | NASDAQ |
| Shares Outstanding | 395.71B |
| Market Cap | 56.59B |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
Latest News
Real Money Post Industrial Average Climbs 9.5% Over November
The RMPIA also tops other indexes for year, shooting ahead 29%.
UK Okays Vaccine, Stimulus Stalls, Facebook's Digital Currency, Micron Guidance
Also, Salesforce posts successful quarter and announces Slack acquisition to effectively take on Microsoft.
Moderna Stock Is Outta Sight
I think I'll just forget to put a new price target on this name for a while. All of my prior sales were mistakes.
A New Strategy as Moderna's Charts Point to Further Gains
Here's where I'd consider taking profits.
I Like UPS More Than FedEx, and Here's My Trade Idea
There are a number of pros for being long either UPS or FDX.
Thankful for Life, Sloppy Wednesday, Sizing Up Salesforce, Keep on Fighting
The battle to gain control over Covid-19 is entering a crucial stage and calls for continued determination.
Jim Cramer: The 10 Tipping Points That Took Us to Dow 30,000
All in all stick with the tipping pointers, they are the drivers of this and the next leg higher.
November to Remember, Energy Roars, Janet Yellen, Transition, 8 Breakout Stocks
Equity markets have run wild since Oct. 30, and it is the more economically sensitive indices that have really taken flight.
Jim Cramer: If the End of the Covid Era Is in Sight, Here Are the Stocks to Buy
I will come back to these names over and over again as we are now in the sweet spot for many.
Big News Is Followed by Little Moves
A lot has happened over the past couple weeks, but little has changed. Let's dig in.
Jim Cramer: Just How Will the Covid-19 Vaccines Be Distributed?
None of these questions have been answered which is why I see chaos ahead as we can't even imagine this process working.
Broadening Market Performance, the Vaccine 'Put', Trading McKesson
Basically, I think we laid out enough reasons for financial markets to revolt, yet they did not.
This Market Is Not as Lackluster as It Appears
Thanksgiving week is often favorable for small-cap trading. We may have seen a preview of that.
Mysterious Mnuchin, Vaccines at the Ready, Carnival Isn't Cruising, 2 Big 'W's
A look at the charts of Advanced Micro Devices and Tesla, plus a review of the 'broadening' market action from Thursday.
The Trap Door, Winter Arrives Early, Lesson of Hiroo Onoda, Fading Consumer
Technical analysis has become so much more accurate a trading tool than it ever was before.
I've Got SunPower on a Covid Day
With coronavirus vaccines on the horizon and a potential 'Green Deal,' I'm brightening up to a trade idea in SPWR.
Why I'm Selling Boeing Shares
The plan is to take off what was a successful trade and reduce the risk, leaving an investment in place somewhat composed of 'house money'.
3 Market Takeaways, Slowing Retail Sales, Nvidia Earnings, Tootsie Roll Squeeze
When Nvidia reports after the bell Wednesday, I'll be focused on three key things.
Jim Cramer: Let's the Check the Weather on Wall Street
Each day you hear analysts talk about headwinds and tailwinds until your head spins -- so let's try to put together a forecast.
Growth Over Value Rotation Unwind - Has It Moved a Bit Too Soon Too Fast?
Sector rotation has been so harsh that it has masked the real fundamentals. There's nothing to say that both sectors and stocks cannot be up.
It's Finally Time for Energy Stocks
One of the most-hated sectors of the market is taking off, and it's not too late to get on board.
Masks on a Wall, Moderna, What Rotation?, Tesla and the S&P 500, Trading Walmart
They called it rotation. I'm still not completely convinced. Don't you normally have to sell something to rotate?
Market Gets Shot in the Arm, but Side Effects Still Unknown
Be aware that major rotation is going on and listen to arguments that optimism over a vaccine might be too high.
Jim Cramer: You Gotta Have Faith
As the Dow hits an all-time high while a pandemic rages on, who are those willing to look through the valley to the good numbers?
Will Moderna's Vaccine Trigger the Same Response as Pfizer's Did?
The rotational nature of this action is making for some tricky trading.
Don't Fight the Trend - But Beware of Chasing
Pursuing stocks that are extended may prove regrettable.
